Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Schering GMP investigation closed

Executive Summary

Newark U.S. attorney's office has closed an investigation on Schering's Puerto Rico manufacturing facility. The inquiry, which was announced in May 2002, focused on the use of unapproved raw materials (1"The Pink Sheet" May 20, 2002, In Brief)...

You may also be interested in...



Schering GMP investigation

The Newark, N.J. U.S. Attorney's Office is spearheading a criminal investigation related to Schering-Plough's Puerto Rico production facilities, Schering confirms (1"The Pink Sheet" May 20, p. 5). The investigation reportedly focuses on use of unapproved raw materials...

Sanofi Tries To Stop Lantus Biosimilar By Getting Supreme Court To Review PTAB, Again

Sanofi seeks to delay decision clearing path for Mylan's Lantus biosimilar; says it should be able to get rehearing based on Federal Circuit's ruling that PTAB judges were not constitutionally appointed.

Sanofi Improperly Listed Lantus Patent In FDA's Orange Book, Appeals Court Finds

First Circuit reverses dismissal of direct purchasers' suit alleging improper listing of patent on device drive mechanism delayed competition; district court to decide if this constitutes antitrust violation.

UsernamePublicRestriction

Register

PS042589

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel